Stocktoria
Fortress Biotech, Inc. FBIO
Fortress Biotech, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.3M | $57.7M | $84.5M | $75.7M | $68.8M | $45.6M | $36.6M | $26.9M | $187.6M | $16.5M |
| R&D expense | — | — | $106.1M | $134.9M | $128.9M | $64.1M | $81.3M | $87.4M | $48.3M | $35.1M |
| SG&A expense | $96.4M | $87.7M | $91.0M | $113.7M | $86.8M | $61.2M | $55.6M | $53.4M | — | — |
| Operating income | -$70.2M | -$110.4M | -$142.3M | -$203.6M | -$188.5M | -$94.3M | -$110.8M | -$120.0M | -$89.8M | -$65.7M |
| Interest expense | — | — | — | — | — | — | — | — | $5.9M | $3.7M |
| Income tax | -$620,000 | $312,000 | $521,000 | $449,000 | $473,000 | $500,000 | $0 | $0 | $1.5M | $0 |
| Net income | $6.8M | -$46.0M | -$60.6M | -$86.6M | -$64.7M | -$46.5M | -$40.0M | -$84.1M | -$66.9M | -$55.1M |
| EPS (diluted) | $-0.07 | $-2.69 | $-8.47 | $-15.97 | $-0.79 | — | — | — | — | — |
| Operating cash flow | -$65.8M | -$80.2M | -$128.2M | -$179.4M | -$116.5M | -$83.7M | -$95.0M | -$98.8M | -$81.3M | -$45.8M |
| Free cash flow | — | -$80.2M | -$128.3M | -$182.1M | -$121.1M | -$85.6M | -$97.3M | -$105.9M | -$82.0M | -$52.2M |
| Cash & equivalents | $79.4M | $57.3M | $80.9M | $178.3M | $305.7M | $233.4M | $136.9M | $65.5M | $95.0M | $105.2M |
| Inventory | $9.6M | $14.4M | $10.2M | $14.2M | $9.9M | $1.4M | $857,000 | $678,000 | $171,000 | $203,000 |
| Total assets | $185.5M | $144.2M | $167.5M | $294.3M | $396.5M | $333.4M | $226.4M | $141.0M | $245.9M | $170.7M |
| Total liabilities | $123.4M | $145.9M | $165.9M | $244.3M | $170.6M | $136.4M | $153.9M | $121.2M | $125.4M | $87.8M |
| Shareholders' equity | $62.2M | $22.7M | $22.5M | $50.0M | $225.9M | $197.0M | $72.5M | $19.7M | $120.5M | $83.0M |
Growth · year-over-year · Revenue CAGR 16.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +9.7% | -31.8% | +11.6% | +10.1% | +50.9% | +24.5% | +36.3% | -85.7% | +1038.3% | +1809.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.